I'd love to see Yole's projections for 2028 - 2038 as that is where Reram's expected revenue could get wild. I reckon WBT is about fairly price based on Yole's 2028 embedded market predictions. However, thats completely discounting discrete advancements and the years after 2028 when WBT might likely multiple its revenue for many years after. Still many bags to go for the patient. My 2 cents.
- Forums
- ASX - By Stock
- WBT
- Ann: Investor Presentation
Ann: Investor Presentation, page-70
Featured News
Add WBT (ASX) to my watchlist
(20min delay)
|
|||||
Last
$3.19 |
Change
-0.100(3.04%) |
Mkt cap ! $605.7M |
Open | High | Low | Value | Volume |
$3.31 | $3.45 | $3.18 | $4.002M | 1.207M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 19867 | $3.19 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$3.20 | 4150 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 19867 | 3.190 |
2 | 8066 | 3.180 |
1 | 10000 | 3.160 |
3 | 11761 | 3.150 |
1 | 1010 | 3.130 |
Price($) | Vol. | No. |
---|---|---|
3.250 | 9127 | 2 |
3.260 | 735 | 1 |
3.380 | 500 | 1 |
3.390 | 10000 | 1 |
3.400 | 2837 | 1 |
Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
Featured News
WBT (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online